- 04:07 PM Chinese mkts slump on stricter bank regulation nor...
- 03:54 PM Den Networks slumps 17% on listing day
- 03:48 PM RIL-RNRL row: Anil Ambani attends SC
- 03:39 PM Asian markets end lower
- 03:38 PM England bid back on track, economic benefits huge:...
- 03:37 PM Sensex ends marginally lower amid volatility; auto...
- 03:36 PM Salary caps will effect developing game says Scuda...
- 03:35 PM Excess stocks to limit Indian wheat imports
- 03:35 PM No strong inflow measures now - PM adviser
- 03:27 PM Thermax can test Rs 690: Akshata Deshmukh



Prabhudas Lilladher has maintained its market performer rating on GlaxoSmithKline Pharmaceuticals with a price target of Rs 1,136 in its May 30, 2008 research report. "Glaxo Smithkline Pharma (GSK) has undertaken new initiatives for future growth of the company. The new initiatives are: 1) Developing channels for hospitals to leverage GSK scale, optimise marketing spends and develop expertise. 2) Develop channels and reach for tapping rural opportunity, expanding matured products through contract field force. 3) Investing in chronic therapeutic segments like diabetes, CVS, biological. Strengthen dermatology and critical care franchises."
"At the CMP of Rs 1,139, the stock trades at 21.5x CY08E EPS of Rs 53 and 19.1x CY09E EPS of Rs 59.8. We maintain Market Performer rating on the scrip with a price target of Rs 1,136 (19x CY09 earnings)," says Lilladher's research report.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
For further details click on attachment......
Attachments : GSKPharma-30-5-08-PL.pdf |
|
Stock Advice
|
|
|
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- Mitesh Thacker's top 5 picks for trade today

- 10 companies that MF managers love
- Ganeshaspeaks: Market prediction for Nov 24
- Den Networks slips 22% after listing at Rs 195
- Trading in MF units to start in 15 days: SEBI

- Will ITC dream run continue beyond FY10?

- Why LyondellBasell is a goldmine for RIL

- Experts see mkts at new highs, advise sectors

- Corrections in '10 to be more aggressive, violent: JPMorgan

- Mahindra may increase car prices due to rising input costs
Source: Business Line
- Renault to continue with M&M for Logan, says Ghosn
Source: Business Line
- Market volatility poses valuation problems: IRDA
Source: Business Line
- Punjab, Haryana buck all-India rice decline trend
Source: Business Line









